Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Experiences about no-reflow in percutaneous transluminal coronary intervention of acute coronary syndrome

View through CrossRef
Aim To analyse the causes and treatments of no-reflow in percutaneous transluminal coronary intervention of acute coronary syndrome patients. Methods Reviewed 68 patients of acute coronary syndrome who undergo percutaneous transluminal coronary intervention during June 2008 to July 2010 in our hospital. The possible reasons, the treatment outcome of immediately or discharged time were observed. Results In all 68 patients, no-reflow was occurred in six cases. One case was dead of carcinogenic shock at the time of 24 h post therapy,. The symptoms as chest distress and chest pain were improved and coronary flow was improved from TIMI 1 flow to TIMI 3 flow after nitroglycerin, verapamil and tirofiban Intracoronary injection alone or in combination. And there was no cardiovascular events occurred until discharged time in those five cases. Conclusion In percutaneous transluminal coronary intervention, no-reflow phenomenon increased risk of operation and mortality. Enhance the knowledge of no-reflow and coped with it timely in right way should improved coronary flow and prognosis of patients.
Title: Experiences about no-reflow in percutaneous transluminal coronary intervention of acute coronary syndrome
Description:
Aim To analyse the causes and treatments of no-reflow in percutaneous transluminal coronary intervention of acute coronary syndrome patients.
Methods Reviewed 68 patients of acute coronary syndrome who undergo percutaneous transluminal coronary intervention during June 2008 to July 2010 in our hospital.
The possible reasons, the treatment outcome of immediately or discharged time were observed.
Results In all 68 patients, no-reflow was occurred in six cases.
One case was dead of carcinogenic shock at the time of 24 h post therapy,.
The symptoms as chest distress and chest pain were improved and coronary flow was improved from TIMI 1 flow to TIMI 3 flow after nitroglycerin, verapamil and tirofiban Intracoronary injection alone or in combination.
And there was no cardiovascular events occurred until discharged time in those five cases.
Conclusion In percutaneous transluminal coronary intervention, no-reflow phenomenon increased risk of operation and mortality.
Enhance the knowledge of no-reflow and coped with it timely in right way should improved coronary flow and prognosis of patients.

Related Results

Early Onset of Coronary Subclavian Steal Syndrome: A Case Report and Literature Review
Early Onset of Coronary Subclavian Steal Syndrome: A Case Report and Literature Review
Abstract Introduction Coronary subclavian steal syndrome (CSSS) is a rare phenomenon that often goes undiagnosed and causes severe complications, including death. This report prese...
Solder Reflow Method and Reflow Temperature Profile
Solder Reflow Method and Reflow Temperature Profile
ABSTRACT The major cause of integrated circuit package failure mechanisms such as delamination, internal cracking or popcorning is package saturation with moistur...
Exploring Temporal Dynamics in No-Reflow Assessment
Exploring Temporal Dynamics in No-Reflow Assessment
Abstract Background For acute ischemic stroke (AIS) patients, successful endovascular thrombectomy (EVT) may not recover functi...
Outcomes of PIANO Score for No-Reflow in Patients Undergoing Primary Percutaneous Coronary Intervention: A Retrospective Study
Outcomes of PIANO Score for No-Reflow in Patients Undergoing Primary Percutaneous Coronary Intervention: A Retrospective Study
BACKGROUND: The no-reflow phenomenon, characterized by inadequate myocardial reperfusion despite successful epicardial vessel revascularization, remains a significant challenge in ...
Cardio protective effect of nicorandil in reperfusion injury among patients undergoing primary percutaneous coronary intervention
Cardio protective effect of nicorandil in reperfusion injury among patients undergoing primary percutaneous coronary intervention
Objectives: To evaluate the effect of nicorandil in prevention of reperfusion injury during primary percutaneous coronary intervention by thrombolysis in myocardial infarction flow...

Back to Top